Humana Inc
HUM: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$812.00 | Tlmvyb | Gyvtlxvq |
Humana Earnings: Strong Medicare Growth and Manageable Medical Utilization Keep Outlook Intact
Narrow-moat Humana turned in strong second-quarter results, and despite growing challenges such as increasing medical utilization in its core Medicare market, the company maintained its near- and longer-term outlook. Given that stability, our $550 fair value estimate does not look likely to change materially at first glance.